GSK plc Gains Losses Arising From Settlements Net Defined Benefit Liability Asset
GSK plc (GLAXF) reported Gains Losses Arising From Settlements Net Defined Benefit Liability Asset of GBP 0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Income Statement › Other Income
ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset · last filed 2026-03-06
| Period end | Gains Losses Arising From Settlements Net Defined Benefit Liability Asset 12 month |
|---|---|
| 2025-12-31 | 0.00 GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | 2.00M GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | 6.00M GBP 20-F · filed 2026-03-06 |
| 2022-12-31 | 21.00M GBP 20-F · filed 2025-03-03 |
| 2021-12-31 | 10.00M GBP 20-F · filed 2024-03-05 |
| 2020-12-31 | 18.00M GBP 20-F · filed 2023-03-10 |
| 2019-12-31 | 9.00M GBP 20-F · filed 2022-03-08 |
| 2018-12-31 | 14.00M GBP 20-F · filed 2021-03-12 |
| 2016-12-31 | 28.00M GBP 20-F · filed 2019-03-15 |
| 2015-12-31 | 8.00M GBP 20-F/A · filed 2018-03-20 |